Home ยป “Novartis Researchers Utilize Biocatalytic Synthesis to Develop Chiral Synthesis Route for Muscarinic M4 Agonists, Identifying Selective M1/M4 Agonists” Or, for a shorter title that still accurately reflects the content of the text: “Chiral Synthesis of Muscarinic M4 Agonists via Biocatalytic Route at Novartis”

“Novartis Researchers Utilize Biocatalytic Synthesis to Develop Chiral Synthesis Route for Muscarinic M4 Agonists, Identifying Selective M1/M4 Agonists” Or, for a shorter title that still accurately reflects the content of the text: “Chiral Synthesis of Muscarinic M4 Agonists via Biocatalytic Route at Novartis”

by satcit

https://pubmed.ncbi.nlm.nih.gov/38116445

Researchers at Novartis have developed a chiral synthesis route for muscarinic M4 agonists using biocatalytic synthesis of spirocyclic diamine building blocks, leading to the identification of selective M1/M4 agonists.

You may also like

Leave a Comment